ClinicalTrials.Veeva

Menu

Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions

University Health Network, Toronto logo

University Health Network, Toronto

Status

Enrolling

Conditions

Brain Metastases
Brain Tumor

Treatments

Diagnostic Test: Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI)

Study type

Interventional

Funder types

Other

Identifiers

NCT05358340
20-6282

Details and patient eligibility

About

The objectives of the study are (1) to evaluate the feasibility of using a combined spin- and gradient- echo (SAGE) sequence in dynamic susceptibility contrast magnetic resonance imaging (DSC MRI) and (2) to determine quantitative estimates of vessel density and size to differentiate between areas of radiation necrosis and tumor recurrence.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with a brain metastasis or primary brain tumour and who will undergo MRI with contrast.

Exclusion criteria

  • Subject or subject's legally authorized representative is unable or unwilling to consent to the study.
  • Subject with documented contrast medium injection contraindication due to severe kidney disease or allergy.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Diagnostic (DSC MRI)
Experimental group
Treatment:
Diagnostic Test: Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI)

Trial contacts and locations

1

Loading...

Central trial contact

Angelica Manalac

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems